These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 33079470

  • 1. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Cui J, Zhang L, Yang L, Zhu YL, Fang H, Chen B, Ning Y, Zhang HZ.
    Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
    [Abstract] [Full Text] [Related]

  • 2. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Cui J, Yang L, Guo L, Shao Y, Tan D, Li N, Zhang H.
    Oncotarget; 2017 Jun 06; 8(23):37845-37854. PubMed ID: 28103579
    [Abstract] [Full Text] [Related]

  • 3. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
    Sun Y, Wu X, Lin H, Lu X, Huang Y, Chi P.
    J Gastrointest Surg; 2021 Apr 06; 25(4):1019-1028. PubMed ID: 32219686
    [Abstract] [Full Text] [Related]

  • 4. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
    Choi JP, Kim SJ, Park IJ, Hong SM, Lee JL, Yoon YS, Kim CW, Lim SB, Lee JB, Yu CS, Kim JC.
    Oncotarget; 2017 Feb 07; 8(6):10375-10384. PubMed ID: 28060748
    [Abstract] [Full Text] [Related]

  • 5. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T, Song C, Kim JS, Kim K, Chie EK, Kang SB, Lee KW, Kim JH, Jeong SY, Kim TY.
    PLoS One; 2015 Feb 07; 10(9):e0138728. PubMed ID: 26381522
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
    Sun Y, Zhang Y, Huang Z, Chi P.
    J Gastrointest Surg; 2019 May 07; 23(5):1006-1014. PubMed ID: 30187336
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Baek JH, Baek DW, Kang BW, Kim HJ, Park SY, Park JS, Choi GS, Kim JG.
    In Vivo; 2020 May 07; 34(4):1993-1999. PubMed ID: 32606172
    [Abstract] [Full Text] [Related]

  • 10. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
    Zhang QQ, Wu YL, Li DD, Shen SH, Fang H, Zhu YL, Zhang HZ.
    Zhonghua Zhong Liu Za Zhi; 2021 May 23; 43(5):574-580. PubMed ID: 34034478
    [Abstract] [Full Text] [Related]

  • 11. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG, Zhou ZX, Wang Z, Liang JW, Hou HR, Zhou HT, Zhang XM, Hu JJ.
    Asian Pac J Cancer Prev; 2014 May 23; 15(13):5365-9. PubMed ID: 25041003
    [Abstract] [Full Text] [Related]

  • 12. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs.
    Tang YL, Li DD, Duan JY, Wang X.
    Int J Colorectal Dis; 2024 Jun 19; 39(1):93. PubMed ID: 38896374
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG, Zhang XF, Wang H, Liu QZ, Ye XZ, Xu C, Wu XB, Cai JH, Zhou ZH, Li JL, Song HY, Luo ZQ, Li P, Ni SC, Jiang L.
    Medicine (Baltimore); 2016 Mar 19; 95(9):e2988. PubMed ID: 26945418
    [Abstract] [Full Text] [Related]

  • 14. [Study on the relationship between tumor regression grade and lymph node regression grade].
    Zhao Q, Fu C, Yu E, Zhang W, Meng R, Wang H, Hao L, Wang H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep 25; 20(9):1050-1054. PubMed ID: 28900999
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Wong IYH, Chung JCY, Zhang RQ, Gao X, Lam KO, Kwong DLW, Chao YK, Law SYK.
    Ann Surg; 2022 Nov 01; 276(5):784-791. PubMed ID: 35876374
    [Abstract] [Full Text] [Related]

  • 18. Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery.
    Li J, Yuan J, Liu H, Yin J, Liu S, Du F, Hu J, Li C, Niu X, Lv B, Xing S.
    Oncotarget; 2016 Mar 29; 7(13):16975-84. PubMed ID: 26934651
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
    Jung W, Kim K, Kim J, Shim SJ.
    In Vivo; 2020 Mar 29; 34(3):1247-1253. PubMed ID: 32354915
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
    Fernández-Aceñero MJ, Granja M, Sastre J, García-Paredes B, Estrada L.
    Virchows Arch; 2016 Apr 29; 468(4):425-30. PubMed ID: 26754675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.